Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure
published in: Alimentary Pharmacology & Therapeutics
date of publication: 2020-09-27
Cites articles
There is nothing here
Article - wd:Q100296530